EPIGENETIC REPROGRAMMING TO TARGET SENESCENT OVARIAN CANCER CELLS AND OVERCOME THERAPEUTIC RESISTANCE FEB 4, 2026, MOD 1 TRANSFERRED AWARD TO WISTAR INSTITUTE
$954,000FY2025Defense Health AgencyDOD
The Wistar Institute Of Anatomy And Biology
The Wistar Institute Of Anatomy And Biology